Patients without CHF | Patients with CHF | ||
---|---|---|---|
Mortality % (95 % CI) | Mortality % (95 % CI) | Adjusteda MRR | |
Overall | 30.4 (28.6–32.4) | 44.6 (39.8–49.7) | 1.2 (1.0–1.5) |
Sex | |||
Male | 27.8 (25.5–30.3) | 38.7 (33.1–45.0) | 1.2 (1.0–1.5) |
Female | 34.5 (31.4–37.7) | 55.5 (47.4–63.9) | 1.3 (1.0–1.7) |
Age | |||
15–39 years | 5.4 (3.1–9.4) | n/ab | n/ab |
40–59 years | 18.5 (15.5–22.0) | 27.1 (16.7–42.0) | 1.5 (0.8–2.7) |
60–79 years | 31.6 (28.8–34.6) | 44.9 (38.2–52.1) | 1.6 (1.2–2.0) |
80+ years | 53.3 (48.9–57.8) | 54.4 (46.3–62.9) | 1.1 (0.8–1.4) |
Modified Charlson Comorbidity Index level | |||
Low (0) | 23.9 (20.9–27.2) | 42.9 (30.0–59.1) | 1.2 (0.7–1.9) |
Intermediate (1–2) | 30.4 (27.4–33.7) | 43.4 (35.4–52.4) | 1.2 (0.9–1.6) |
High (3+) | 37.2 (33.7–40.9) | 45.7 (39.3–52.5) | 1.3 (1.0–1.7) |